Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Macrolide and occult infection in asthma.

Mario Cazzola1, Maria Gabriella Matera, Francesco Blasi

  • 1A. Cardarelli Hospital, Department of Respiratory Medicine, Unit of Pneumology and Allergology, Naples, Italy. mcazzola@qubisoft.it

Current Opinion in Pulmonary Medicine
|January 30, 2004
PubMed
Summary

Atypical bacteria may cause asthma exacerbations. Macrolides, with antimicrobial and anti-inflammatory effects, show potential in treating asthma by reducing airway inflammation and improving symptoms, though more research is needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry.

The European respiratory journal·2022
Same author

The Prescribing Practice for COPD: Relationship to Circadian Rhythm, Disease Severity, and Clinical Phenotype in the STORICO Observational Study.

Advances in therapy·2022
Same author

The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study.

American journal of hematology·2022
Same author

Corrigendum to 'External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019'.

European journal of internal medicine·2022
Same author

Lung Transplant for ARDS after COVID-19: Long-Term Outcomes and Considerations about Detrimental Issues.

Journal of clinical medicine·2022
Same author

Comparison between the first and second COVID-19 waves in Internal Medicine wards in Milan, Italy: a retrospective observational study.

Internal and emergency medicine·2022

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • Asthma exacerbations are sometimes linked to atypical bacterial infections (e.g., Chlamydia pneumoniae, Mycoplasma pneumoniae).
  • These pathogens may contribute to chronic airway inflammation and nonatopic asthma in adults.
  • Current asthma treatment guidelines do not routinely recommend antibiotics for exacerbations, creating a therapeutic gap.

Purpose of the Study:

  • To review the role of antimicrobials, particularly macrolides, tetracyclines, and fluoroquinolones, in asthma treatment.
  • To evaluate the potential benefits of macrolides in managing asthma, considering their dual antimicrobial and anti-inflammatory properties.

Main Methods:

  • Literature review of studies investigating atypical pathogens and macrolide use in asthma.

Related Experiment Videos

  • Analysis of macrolide mechanisms, including antimicrobial activity and anti-inflammatory effects on airway cells.

    • Main Results:

    • Macrolides possess both antimicrobial activity against atypical pathogens and anti-inflammatory properties.
    • Evidence suggests macrolides may reduce airway inflammation by decreasing cytokine mRNA transcription and inhibiting interleukin-8 release.
    • Observed improvements in asthma symptoms and pulmonary function are not attributed to bronchodilation or steroid-sparing effects.

    Conclusions:

    • Clinical evidence tentatively supports macrolide use in asthma due to their antimicrobial action.
    • Further high-quality, controlled studies are necessary to confirm the efficacy of macrolides in asthma treatment.
    • Current supporting studies are limited by open, uncontrolled designs, impacting their scientific value.